Prognostic impact of 18 F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer.
Hye Lim ParkSea-Won LeeJi Hyung HongJieun LeeAhwon LeeSoo Jin KwonSonya Youngju ParkIe Ryung YooPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
Metabolic parameters derived from preoperative PET/CT was significantly associated with recurrence in stage II IDC primarily treated with surgery. PET/CT can be a powerful prognostic tool in conjunction with novel staging systems and current biomarkers for patients undergoing contemporary therapy. Our results urge to reconsider the currently underestimated value of PET/CT confined to diagnostic aspect and to newly recognize its prognostic impact in these intermediate-risk breast cancer.
Keyphrases
- pet ct
- patients undergoing
- positron emission tomography
- minimally invasive
- neoadjuvant chemotherapy
- squamous cell carcinoma
- coronary artery bypass
- coronary artery disease
- computed tomography
- acute coronary syndrome
- breast cancer risk
- lymph node
- young adults
- free survival
- newly diagnosed
- surgical site infection
- replacement therapy
- smoking cessation